Trade Ideas June 11, 2026 09:15 AM

Intel at the Crossroads: A Tactical Long as Foundry Wins Meet a Rich Multiple

A high-conviction trade that leans long into Intel's foundry momentum while protecting capital against execution and valuation risk.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
INTC

Intel is trading near $116.56 after a dramatic recovery from its 2025 lows. The company's foundry business is now material to the top line, and recent reports of large customer interest create a plausible path to earnings normalization. Valuation is stretched (EV/sales ~10.5, negative EPS), so this is a high-risk, event-driven trade: size it like a trade, not a core position. Entry $116.56, stop $102.00, target $132.00, horizon 180 trading days.

Intel at the Crossroads: A Tactical Long as Foundry Wins Meet a Rich Multiple
INTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Intel's foundry (IFS) generated $5.4B in Q1 2026 and accounts for ~40% of revenue.
  • Company trades at a market cap near $585.8B with EV/sales ~10.5x and EV/EBITDA ~42.8x, pricing significant future profit improvement.
  • Trade: Long at $116.56, stop $102.00, target $132.00, horizon long term (180 trading days); treat as high-risk, event-driven position.
  • Balance sheet looks serviceable (current ratio 2.31, debt/equity 0.4), but free cash flow is negative (~-$3.12B).

Hook / Thesis

Intel is closer to a decisive inflection than the market gives it credit for. The company’s foundry business is no longer a sideline; it contributed roughly $5.4 billion in revenue in Q1 2026 and now represents about 40% of Intel’s top line. Those are the kinds of numbers that can seed a multi-quarter re-rate if the business converts pilot orders into repeatable, profitable volume.

At the same time, the stock is pricing a lot of optimism. Intel trades at a market capitalization near $585.8 billion and an enterprise value of roughly $565.8 billion, with EV/sales near 10.5 and a negative bottom line. That combination - accelerating operational momentum on one hand, stretched valuation on the other - makes now a classic make-or-break window for the company. This trade attempts to capture upside from further foundry traction while keeping losses tightly managed if execution or margin improvement disappoints.

Business primer - why investors should care

Intel is a vertically integrated semiconductor company operating across Client Computing, Data Center & AI (DCAI), Intel Foundry Services (IFS), and other corporate activities. The recent strategic pivot is obvious: IFS is scaling fast and already contributes meaningful revenue. Reported Q1 2026 foundry revenue of $5.4 billion was up about 16% year-over-year and represents roughly 40% of company revenue - a structural shift from Intel’s legacy identity as primarily a CPU designer for PCs and servers.

Why it matters: advanced-node fabs are high-capex, high-barrier assets. Winning significant orders from customers like Google or showing compatibility with major design partners (reports indicate Nvidia evaluating Intel’s 18A node) does two things - it validates process tech, and it converts fixed-capex investment into recurring fab throughput and margin expansion. The market tends to reward companies that move from capex consumption into steady, growing fab throughput because the revenue and margin profiles change materially.

What the numbers say

Metric Value
Current price $116.56
Market cap $585,831,062,600
Enterprise value $565,767,040,000
EV / Sales ~10.5x
EV / EBITDA ~42.8x
Free cash flow (most recent) - $3.119B
Foundry (IFS) revenue Q1 2026 $5.4B (up 16% YoY)
IFS share of top line ~40%
Balance sheet Current ratio 2.31, Quick 1.85, Debt/Equity 0.4

Those numbers show a company in transition: solid working-capital metrics and modest leverage, plus significant negative free cash flow that reflects ongoing capex and investment. The pricing multiple assumes future profits that are not yet realized. That makes Intel sensitive to both positive delivery (customer ramps, margin improvement) and negative surprises (slower node yields, price competition).

Technical and market conditions

On the technical side, price momentum has been constructive: the stock sits above its 10-, 20-, and 50-day simple moving averages (10d ~ $109.73, 20d ~ $113.22, 50d ~ $94.15), signaling near-term bullishness. However, MACD shows bearish momentum signaling that the latest leg up may be consolidating. Average daily volume is high historically (~128M), but today’s volume is light (~17M), so any decisive move should be volume-confirmed. Short interest equates to roughly a one-day cover ratio, which limits extreme squeeze dynamics but not directional pressure.

Catalysts to watch (2-5)

  • Large foundry wins becoming public or confirmed - reports of multi-million-unit TPU orders or new customer qualifications for 18A would materially de-risk revenue growth expectations.
  • Sequential margin improvement in DCAI/IFS - any evidence that foundry throughput and yields are improving could change the valuation narrative.
  • Government or strategic funding headlines - past conversion of CHIPS Act funding into Intel shares has shown how policy can influence capital structure and perception; similar moves or continued government support would be a positive.
  • Quarterly results showing conversion of backlog into revenue and narrowing of negative EPS trajectory.

Trade plan (actionable)

Direction: Long

Entry: Buy at $116.56.

Stop loss: $102.00. This stop is below the recent consolidation and leaves room for noise while protecting against a sharp downside turn if foundry momentum falters or macro liquidity tightens.

Target: $132.00. This target sits just below the 52-week high and offers a realistic payoff if the market rewards a continued execution story and valuation re-rate.

Position sizing & risk: Treat this as a trade, not a full-sized conviction position. Given stretched multiples and execution risk, limit position size such that a stop-out at $102 represents no more than 2-3% of total portfolio capital.

Horizon: Long term (180 trading days). The thesis requires time for foundry backs to convert to revenue, for yields to improve, and for the market to re-rate on clearer profit trajectory. Shorter holds are possible: if Intel announces a material foundry win or shows step-function margin improvement, take profits earlier. Conversely, use mid term (45 trading days) as a checkpoint to reevaluate on quarterly data.

Why this trade (brief rationale)

We are buying a binary outcome priced into a company that is already well above its prior trough. The upside - a sustainable foundry ramp and margin expansion - is material because IFS already contributes ~40% of revenue. The downside is capped by a tight stop that limits exposure to execution failure. The risk/reward is asymmetric if Intel can demonstrate durable revenue and margin improvement from its fabs; it is unattractive if those metrics remain slipstreamed by yield and pricing pressure.

Risks and counterarguments (at least 4 risks + counterargument)

  • Execution risk - Foundry economics hinge on yields, cycle time, and customer qualification. Poor yields or delayed node maturity would crush margins and revenue ramp timing.
  • Valuation risk - The stock's EV/sales (~10.5x) and high EV/EBITDA (~42.8x) assume significant future profitability. Any miss on earnings or slower-than-expected margin expansion could prompt a large multiple contraction.
  • Macroeconomic / demand shock - A broader tech downturn or cyclically weak AI/Cloud capex could reduce demand for advanced nodes and delay customer orders.
  • Competitive dynamics - TSMC and Samsung remain formidable; wins by those incumbents or superior process economics from competitors could squeeze Intel’s pricing and share gains.
  • Funding & policy dependence - Past government involvement has been material to perception. If policy support weakens or becomes politicized, that could reduce strategic tailwinds.

Counterargument: The primary bear case is that the market has already priced a best-case execution scenario into Intel’s valuation — and that’s plausible. The company still reports negative free cash flow (-$3.119B) and negative EPS. If the foundry business scales but at lower-than-expected margins, the stock could trade significantly lower even with revenue growth. That’s why this trade is sized conservatively and protected with a hard stop.

What would change my mind

I would abandon a bullish stance if any of the following happen: (1) sequential foundry revenue growth stalls or reverses; (2) margin trends in DCAI/IFS fail to improve or deteriorate; (3) company guidance trims materially below consensus; (4) macro shock meaningfully reduces cloud/AI capex. Conversely, I would add to the position if Intel posts consecutive quarters of strong foundry revenue growth, material margin expansion, and public confirmation of multi-year, large-volume customer commitments.

Conclusion

This is a make-or-break period for Intel. The potential upside from a proven foundry ramp is substantial and not purely hypothetical: IFS already contributes materially to revenue, and strategic customers appear interested in advanced nodes. But valuation is demanding and execution risk is real. The proposed trade captures upside with disciplined risk control: buy at $116.56, stop at $102.00, and target $132.00 over a long-term window of 180 trading days. Size the trade like an event-driven bet and watch the next several quarters closely - they will tell you whether Intel has indeed turned the corner or simply rerated into a more exposed valuation.

Risks

  • Execution risk: poor yields or delayed node maturity could derail the foundry ramp.
  • Valuation contraction if revenue growth or margin improvement disappoints given high EV/sales and EV/EBITDA.
  • Macroeconomic shock or reduced AI/cloud capex could slow customers' fab orders.
  • Competitive pressure from TSMC and Samsung on pricing and process maturity could limit market share gains.

More from Trade Ideas

Buying Microsoft on the Pullback: A Risk-Managed Swing Trade Jun 11, 2026 Buy First Solar on This Pullback — 2027 Growth Isn’t Fully Priced Jun 11, 2026 Cullinan Therapeutics: Event-Driven Swing Trade Into Clinical Optionality Jun 11, 2026 Nvidia: Buy the AI Compute Re-acceleration — Tactical Long into a Clear Demand Shock Jun 11, 2026 Uber Is Shifting From Growth to Profit - The Platform Is Ready for a Re-rate Jun 11, 2026